| CIRAX | CVLCX | CIRAX / CVLCX | |
| Total Expense Ratio | 0.62 | 1.97 | 31% |
| Annual Report Gross Expense Ratio | 0.62 | 2.20 | 28% |
| Fund Existence | 24 years | 29 years | - |
| Gain YTD | 19.214 | 16.316 | 118% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 122B | 316M | 38,608% |
| Annual Yield % from dividends | 2.89 | 0.23 | 1,233% |
| Returns for 1 year | 14.98 | 4.78 | 313% |
| Returns for 3 years | 41.59 | 46.00 | 90% |
| Returns for 5 years | 55.48 | 24.65 | 225% |
| Returns for 10 years | 100.68 | 51.10 | 197% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DIEYX | 47.36 | 0.19 | +0.40% |
| BNY Mellon International Core Equity Y | |||
| OIEQX | 26.66 | 0.10 | +0.38% |
| JPMorgan Equity Income R4 | |||
| FLMIX | 10.61 | 0.02 | +0.19% |
| Meeder Muirfield Institutional | |||
| GALLX | 21.59 | N/A | N/A |
| Goldman Sachs Enhanced U.S. Equity A | |||
| TISEX | 20.98 | -0.04 | -0.19% |
| Nuveen Quant Small Cap Equity R6 | |||